Join
Live feed
·
INSIDERFilingvia Quantisnow
Lumos Pharma Inc. logo

Director Raffin Thomas A. returned 9,406 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LUMO· Lumos Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LUMO (Lumos Pharma Inc.) and more on Quantisnow.